Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Other Non-Current Assets (2022 - 2026)

Compass Therapeutics' Other Non-Current Assets history spans 5 years, with the latest figure at $568000.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% to $568000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $568000.0, a 0.0% change, with the full-year FY2025 number at $568000.0, changed 0.0% from a year prior.
  • Other Non-Current Assets hit $568000.0 in Q1 2026 for Compass Therapeutics, roughly flat from $568000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for CMPX hit a ceiling of $568000.0 in Q3 2024 and a floor of $320000.0 in Q4 2022.
  • Historically, Other Non-Current Assets has averaged $444000.0 across 5 years, with a median of $444000.0 in 2022.
  • Biggest five-year swings in Other Non-Current Assets: changed 0.0% in 2023 and later soared 77.5% in 2024.
  • Tracing CMPX's Other Non-Current Assets over 5 years: stood at $320000.0 in 2022, then changed by 0.0% to $320000.0 in 2023, then skyrocketed by 77.5% to $568000.0 in 2024, then changed by 0.0% to $568000.0 in 2025, then changed by 0.0% to $568000.0 in 2026.
  • Business Quant data shows Other Non-Current Assets for CMPX at $568000.0 in Q1 2026, $568000.0 in Q4 2025, and $568000.0 in Q3 2025.